Key Record Dates
ClinicalTrials.gov Identifier: | NCT02823405 |
---|---|
Brief Title: | X4P-001 and Pembrolizumab in Patients With Advanced Melanoma (X4P-001-MELA) |
First Submitted : | July 1, 2016 |
First Submitted that Met QC Criteria : | July 1, 2016 |
First Posted : | July 6, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | July 1, 2020 |
Last Update Posted : | July 7, 2020 |